$461 Million is the total value of Ghost Tree Capital, LLC's 42 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 43.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $225,820,000 | – | 500,000 | +100.0% | 49.01% | – |
| XBI | New | SPDR SER TRcall | $26,964,000 | – | 300,000 | +100.0% | 5.85% | – |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $16,430,000 | -35.7% | 140,000 | -26.3% | 3.57% | -61.1% |
| COGT | COGENT BIOSCIENCES INC | $12,733,000 | -12.7% | 1,700,000 | 0.0% | 2.76% | -47.1% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $12,703,000 | -17.3% | 250,000 | -23.1% | 2.76% | -49.9% |
| MRUS | Buy | MERUS N V | $10,576,000 | -5.0% | 400,000 | +14.3% | 2.30% | -42.5% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $10,417,000 | +80.4% | 1,100,000 | +120.0% | 2.26% | +9.2% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $10,416,000 | +91.6% | 325,000 | +30.0% | 2.26% | +16.0% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $10,218,000 | -24.4% | 300,000 | -14.3% | 2.22% | -54.3% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $8,624,000 | -12.8% | 466,403 | -6.7% | 1.87% | -47.1% |
| KRTX | New | KARUNA THERAPEUTICS INC | $7,607,000 | – | 60,000 | +100.0% | 1.65% | – |
| ISEE | Sell | IVERIC BIO INC | $7,574,000 | -27.5% | 450,000 | -28.0% | 1.64% | -56.1% |
| ARVN | ARVINAS INC | $7,403,000 | -18.1% | 110,000 | 0.0% | 1.61% | -50.4% | |
| PCVX | Buy | VAXCYTE INC | $7,245,000 | +21.8% | 300,000 | +20.0% | 1.57% | -26.3% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $6,648,000 | +59.0% | 400,000 | +60.0% | 1.44% | -3.7% |
| AXSM | New | AXSOME THERAPEUTICS INCput | $6,209,000 | – | 150,000 | +100.0% | 1.35% | – |
| CTIC | Buy | CTI BIOPHARMA CORP | $6,071,000 | +104.0% | 1,300,000 | +8.3% | 1.32% | +23.4% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $5,691,000 | – | 350,000 | +100.0% | 1.24% | – |
| RAPT | Sell | RAPT THERAPEUTICS INC | $5,498,000 | -57.2% | 250,000 | -28.6% | 1.19% | -74.1% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $4,388,000 | – | 100,000 | +100.0% | 0.95% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $3,911,000 | – | 94,500 | +100.0% | 0.85% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $3,911,000 | -40.4% | 225,000 | -25.0% | 0.85% | -63.9% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $3,906,000 | -56.6% | 50,000 | -50.0% | 0.85% | -73.7% |
| VRNA | VERONA PHARMA PLCsponsored ads | $3,743,000 | -25.7% | 750,000 | 0.0% | 0.81% | -55.0% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $3,691,000 | -45.1% | 80,000 | 0.0% | 0.80% | -66.8% | |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $3,230,000 | +11.8% | 200,000 | +48.1% | 0.70% | -32.3% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $3,172,000 | -65.8% | 200,000 | -52.9% | 0.69% | -79.3% |
| XENE | XENON PHARMACEUTICALS INC | $3,057,000 | -2.1% | 100,000 | 0.0% | 0.66% | -40.8% | |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $2,699,000 | -40.1% | 100,000 | -50.0% | 0.59% | -63.7% |
| Sell | AADI BIOSCIENCE INC | $2,546,000 | -47.3% | 150,000 | -25.0% | 0.55% | -68.1% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,155,000 | -54.4% | 125,000 | -61.5% | 0.47% | -72.4% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $2,018,000 | -47.2% | 120,000 | -29.4% | 0.44% | -68.1% |
| NMTR | 9 METERS BIOPHARMA INC | $1,948,000 | -38.8% | 3,250,000 | 0.0% | 0.42% | -62.9% | |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $1,866,000 | -44.5% | 85,000 | -28.2% | 0.40% | -66.4% |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $1,800,000 | -55.8% | 473,562 | -47.6% | 0.39% | -73.2% |
| LPTX | Sell | LEAP THERAPEUTICS INC | $1,739,000 | -60.2% | 993,714 | -26.4% | 0.38% | -76.0% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $1,644,000 | -62.6% | 20,000 | -33.3% | 0.36% | -77.4% |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $1,631,000 | -58.2% | 1,315,154 | -34.2% | 0.35% | -74.7% |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $1,579,000 | – | 686,599 | +100.0% | 0.34% | – |
| Buy | PARDES BIOSCIENCES INC | $614,000 | -25.0% | 85,000 | +70.0% | 0.13% | -54.8% | |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $405,000 | -83.3% | 100,000 | -55.6% | 0.09% | -89.9% |
| Sell | PYXIS ONCOLOGY INC | $303,000 | -90.6% | 75,000 | -74.6% | 0.07% | -94.3% | |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -135,000 | -100.0% | -0.18% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INCcall | $0 | – | -300,000 | -100.0% | -0.43% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -55,000 | -100.0% | -0.52% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -165,000 | -100.0% | -0.57% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -60,000 | -100.0% | -0.63% | – |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -100,000 | -100.0% | -0.84% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -225,000 | -100.0% | -1.13% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -450,000 | -100.0% | -1.30% | – |
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -210,000 | -100.0% | -1.66% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -1.82% | – |
| BLU | Exit | BELLUS HEALTH INC NEWput | $0 | – | -891,000 | -100.0% | -2.57% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -3.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.